Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Real-world durability challenges with nAMD treatments and the potential promise of gene therapy.
Journal: Current medical research and opinion
Published: May 14, 2026
Cost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial.
Journal: American journal of ophthalmology
Published: April 19, 2026
Correction: Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis.
Journal: Ophthalmology and therapy
Published: August 13, 2025
Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis.
Journal: Ophthalmology and therapy
Published: April 29, 2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.
Journal: Immunotherapy
Published: January 17, 2025
Gene therapy for AMD: better as an adjuvant than a replacement - Authors' reply.
Journal: Lancet (London, England)
Published: January 14, 2025
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE.
Journal: American journal of ophthalmology
Published: December 20, 2024
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.
Journal: Journal of vitreoretinal diseases
Published: December 10, 2024
Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1.
Journal: Ophthalmology science
Published: December 06, 2024
Infographic: Efficacy and safety of high-dose Intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration: week 48 results from the phase 3 PULSAR trial.
Journal: Eye (London, England)
Published: November 21, 2024
Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration.
Journal: Therapeutic advances in ophthalmology
Published: November 19, 2024
Last Updated: 09/26/2026